Literature DB >> 26366051

Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

Timothy J Lyons1, Alicia J Jenkins1.   

Abstract

Modifications of extant plasma proteins, structural proteins, and other macromolecules are enhanced in diabetes because of increased glycation (secondary to increased glucose concentrations) and perhaps because of increased oxidative stress. Increased glycation is present from the time of onset of diabetes, but the relation between diabetes and oxidative stress is less clear: increased oxidative stress may occur later in the course of disease, as vascular damage becomes established, or it may be a feature of uncomplicated diabetes. The combined effects of protein modification by glycation and oxidation may contribute to the development of accelerated atherosclerosis in diabetes and to the development of microvascular complications. Thus, even if not increased by diabetes, variations in oxidative stress may modulate the consequences of hyperglycemia in individual diabetic patients. In this review, the close interaction between glycation and oxidative processes is discussed, and the theme is developed that the most significant modifications of proteins are the result of interactions with reactive carbonyl groups. While glucose itself contains a carbonyl group that is involved in the initial glycation reaction, the most important and reactive carbonyls are formed by free radical-oxidation reactions damaging either carbohydrates (including glucose itself) or lipids. The resulting carbonyl-containing intermediate products then modify proteins, yielding "glycoxidation" and "lipoxidation" products, respectively. This common pathway for glucose and lipid-mediated stress, which may contribute to diabetic complications, is the basis for the carbonyl stress hypothesis for the development of diabetic complications.

Entities:  

Year:  1997        PMID: 26366051      PMCID: PMC4567260     

Source DB:  PubMed          Journal:  Diabetes Rev (Alex)        ISSN: 1066-9442


  215 in total

1.  N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.

Authors:  S Reddy; J Bichler; K J Wells-Knecht; S R Thorpe; J W Baynes
Journal:  Biochemistry       Date:  1995-08-29       Impact factor: 3.162

2.  Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

Authors:  U P Steinbrecher; J L Witztum
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

3.  Nonenzymatic glycosylation of protein does not increase with age in normal human lenses.

Authors:  J S Patrick; S R Thorpe; J W Baynes
Journal:  J Gerontol       Date:  1990-01

4.  Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications.

Authors:  V Vishwanath; K E Frank; C A Elmets; P J Dauchot; V M Monnier
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

5.  Expression of receptors for advanced glycosylated end-products in renal disease.

Authors:  M Abel; U Ritthaler; Y Zhang; Y Deng; A M Schmidt; J Greten; T Sernau; P Wahl; K Andrassy; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

6.  Formation of reactive intermediates from Amadori compounds under physiological conditions.

Authors:  D V Zyzak; J M Richardson; S R Thorpe; J W Baynes
Journal:  Arch Biochem Biophys       Date:  1995-01-10       Impact factor: 4.013

7.  Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.

Authors:  G Bellomo; E Maggi; M Poli; F G Agosta; P Bollati; G Finardi
Journal:  Diabetes       Date:  1995-01       Impact factor: 9.461

8.  Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications.

Authors:  F Curcio; A Ceriello
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

9.  Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor.

Authors:  R Bucala; R Mitchell; K Arnold; T Innerarity; H Vlassara; A Cerami
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

10.  Effect of in vitro non-enzymatic glycosylation of human skin collagen on susceptibility to collagenase digestion.

Authors:  T J Lyons; L Kennedy
Journal:  Eur J Clin Invest       Date:  1985-06       Impact factor: 4.686

View more
  24 in total

1.  Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides.

Authors:  Annunziata Lapolla; Domenico Fedele; Rachele Reitano; Nadia Concetta Aricò; Roberta Seraglia; Pietro Traldi; Ester Marotta; Roberto Tonani
Journal:  J Am Soc Mass Spectrom       Date:  2004-04       Impact factor: 3.109

Review 2.  Non-enzymatic molecular damage as a prototypic driver of aging.

Authors:  Alexey Golubev; Andrew D Hanson; Vadim N Gladyshev
Journal:  J Biol Chem       Date:  2017-03-06       Impact factor: 5.157

Review 3.  Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers.

Authors:  Timothy J Lyons; Arpita Basu
Journal:  Transl Res       Date:  2012-01-31       Impact factor: 7.012

4.  Cellular antioxidant enzyme activity and biomarkers for oxidative stress are affected by heat stress.

Authors:  Walid S Habashy; Marie C Milfort; Romdhane Rekaya; Samuel E Aggrey
Journal:  Int J Biometeorol       Date:  2019-07-27       Impact factor: 3.787

5.  Anti-glycation and anti-oxidative effects of a phenolic-enriched maple syrup extract and its protective effects on normal human colon cells.

Authors:  Weixi Liu; Zhengxi Wei; Hang Ma; Ang Cai; Yongqiang Liu; Jiadong Sun; Nicholas A DaSilva; Shelby L Johnson; Louis J Kirschenbaum; Bongsup P Cho; Joel A Dain; David C Rowley; Zahir A Shaikh; Navindra P Seeram
Journal:  Food Funct       Date:  2017-02-22       Impact factor: 5.396

6.  LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

Authors:  J L Figarola; S Scott; S Loera; C Tessler; P Chu; L Weiss; J Hardy; S Rahbar
Journal:  Diabetologia       Date:  2003-07-05       Impact factor: 10.122

7.  Oxidative Stress Correlates with Complications Among Diabetic Patients Attending a Diabetic Clinic in Muhimbili National Hospital, Dar es Salaam, Tanzania.

Authors:  Solomon Genet; Yakobo Lema; Janne Lutale
Journal:  Indian J Clin Biochem       Date:  2012-11-07

8.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

9.  N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.

Authors:  Khaled A Ahmed; Sekaran Muniandy; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

10.  Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase.

Authors:  Yunzhou Dong; Yong Wu; Mingyuan Wu; Shuangxi Wang; Junhua Zhang; Zhonglin Xie; Jian Xu; Ping Song; Kenneth Wilson; Zhengxing Zhao; Timothy Lyons; Ming-Hui Zou
Journal:  J Cell Mol Med       Date:  2008-06-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.